The relationship between the triglyceride-glucose index (TyG) and all-cause and cardiovascular mortality in biological aging (BA) populations remains unclear. This study aimed to investigate the role of TyG and its derived indices (TyG-Body Mass Index TyG-BMI and TyG-Waist-to-Height Ratio TyG-WHtR) as potential biomarkers of mortality risk in biologically aging populations. This study included participants from the National Health and Nutrition Examination Survey database between 1999 and 2018 and constructed 3 metabolism-related indices: TyG, TyG-BMI, and TyG-WHtR. Kaplan–Meier survival curves, Cox regression analysis, trend tests, and restricted cubic splines were used to assess the relationship between TyG-related indices and all-cause and cardiovascular mortality in BA populations (including Klemera–Doubal biological age acceleration KDM-BA and phenotypic age acceleration PA). Subgroup and interaction analyses were performed. Survival analysis showed that, in the KDM-BA population, higher quartiles of TyG, TyG-BMI, and TyG-WHtR were significantly associated with worse survival outcomes. In the PA population, higher TyG and TyG-WHtR levels also indicated worse survival ( P < .001 for both), but no significant difference was found for TyG-BMI in all-cause mortality ( P = .313). Fully adjusted Cox regression analysis further confirmed that in the KDM-BA population, TyG and its related indices were significantly associated with both all-cause and cardiovascular mortality hazard ratio (HR range: 1.19–1.34, P < .05). In the PA population, TyG was significantly associated with both types of mortality (HR range: 1.16–1.19, P < .05), whereas TyG-WHtR was only associated with cardiovascular mortality (HR = 1.26, P = .022). TyG-BMI was not significantly associated with either type of mortality. Nonlinear analysis revealed a significant dose-response relationship between TyG and mortality in both populations, with the mortality risk significantly increasing above a certain threshold (approximately 8.1). In the PA population, TyG-BMI and TyG-WHtR showed significant nonlinear relationships with all-cause mortality. Specifically, when TyG-BMI exceeded 215.145, the risk of death increased significantly (HR = 1.00, P = .031, nonlinear P < .001), and when TyG-WHtR exceeded 5.034, the risk of death also increased significantly (HR = 1.20, P < .001, nonlinear P = .004). Subgroup analysis showed that the association between TyG and its related indices and mortality risk was stronger in individuals aged < 65 years and those with higher BA (e.g., KDM-BA and PA ≥ 5). Medication use had a limited effect on these associations, with only minor enhancements observed in some subgroups. This study underscores the significance of TyG and its related indices (TyG-BMI and TyG-WHtR) as key indicators of all-cause and cardiovascular mortality in biologically aging populations. Notably, strong associations were found in the KDM-BA cohort, particularly among individuals aged < 65 years and those with advanced BA. These findings suggest that TyG and its related indices may play a crucial role in the long-term management of biologically aging populations and serve as valuable biomarkers for identifying high-risk individuals. This further highlights the importance of metabolic dysregulation in the aging process and its contribution to an increased mortality risk.
Cheng et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: